Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Comprehensive Assessment of the Impact of Gender-Affirming Hormone Therapy on Cardiovascular Risk, Metabolic Health, and Mood Disorders in Transgender Individuals.

NCT07394400 is registered in ClinicalTrials.gov with Milagros Rocha Barajas as lead sponsor.

NCT NCT07394400
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07394400 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Comprehensive Assessment of the Impact of Gender-Affirming Hormone Therapy on Cardiovascular Risk, Metabolic Health, and Mood Disorders in Transgender Individuals.
Lead sponsor
Milagros Rocha Barajas
Phase
Observational
Overall status
Not yet recruiting
Start date
February 14, 2026
Completion date
December 31, 2029
Enrollment
94 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

transgender individuals